S-1 · primary offering
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
IDXG$5.44-2.68%
Interpace Biosciences, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - Diagnostics & ResearchCountry: USExchange: OTC
Mkt Cap:$32.12M
Float & O/S:889.5K / 5.9M
Inst Own:Not measured
DilutionScan read 24 of INTERPACE BIOSCIENCES, INC.'s SEC filings and found 1 convertible and 1 S-1 registration on file for IDXG. The latest dilution event on file is a registration statement on Sep 25, 2026. Analysis updated Nov 4, 2026.
Signal8 Summary
Raise routes on file: pending S-1 · latest dilution event 40 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 25, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Filed
Series C Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Know who's about to sell into your IDXG trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
